Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

WORK Medical Technology (WOK) Intangibles (2023 - 2025)

Historic Intangibles for WORK Medical Technology (WOK) over the last 3 years, with Q3 2025 value amounting to $959116.0.

  • WORK Medical Technology's Intangibles fell 813.61% to $959116.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $959116.0, marking a year-over-year decrease of 813.61%. This contributed to the annual value of $959116.0 for FY2025, which is 813.61% down from last year.
  • According to the latest figures from Q3 2025, WORK Medical Technology's Intangibles is $959116.0, which was down 813.61% from $975622.0 recorded in Q1 2025.
  • In the past 5 years, WORK Medical Technology's Intangibles ranged from a high of $1.0 million in Q3 2024 and a low of $959116.0 during Q3 2025
  • Moreover, its 3-year median value for Intangibles was $987036.0 (2023), whereas its average is $994312.5.
  • Its Intangibles has fluctuated over the past 5 years, first surged by 456.83% in 2024, then plummeted by 813.61% in 2025.
  • WORK Medical Technology's Intangibles (Quarter) stood at $998450.0 in 2023, then rose by 4.57% to $1.0 million in 2024, then decreased by 8.14% to $959116.0 in 2025.
  • Its Intangibles stands at $959116.0 for Q3 2025, versus $975622.0 for Q1 2025 and $1.0 million for Q3 2024.